Kristen Fortney is the CEO and co-founder of BioAge, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop new therapies for obesity and metabolic diseases. Kristen’s scientific background is in aging biology and bioinformatics. She received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford. She serves as an advisor to multiple biotechnology companies.